Michelin today marked the opening of its newest plant in North America, which will produce the innovative MICHELIN® X® TWEEL® Airless Radial Tire™ for commercial applications.
An idea first conceived by Michelin research engineers in the United States, the TWEEL is a revolutionary non-pneumatic tire that changed the configuration of a conventional tire, bringing together the tire and the wheel assembly into one solid unit. The TWEEL comprises a rigid hub connected to a shear beam by means of flexible, deformable polyurethane spokes, all functioning as a single unit.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7381451-michelin-open-s-first-manufacturing-plant-tweel-airless-radial-tire/
Las Vegas launches the latest “What Happens Here, Stays Here” commercial today, titled “Transformation.” The 30-second spot makes its debut, along with a series of digital and social extensions. For more than 10 years, the iconic campaign has celebrated adult freedom, and “Transformation” illustrates the clandestine freedom people experience in Las Vegas while instilling the destination’s message of: be yourself or anyone else.
The narrative follows the journey of lead male and female characters as they spend the day crossing paths with their appearances evolving at each location. The lead characters come together at the end of the commercial as Imagine Dragons performs their latest single, “I Bet My Life.” The destination was eager to work with the Las Vegas quartet on the pop-culture entrenched campaign as it continues to elevate Las Vegas as the “Entertainment Capital of the World.”
To view the Multimedia News Release, go http://www.multivu.com/players/English/63040-las-vegas-what-happens-here-stays-here/
Click: http://www.itsmeandre.net "Hold Me Down" by Andre. First single off the upcoming album, Andre. Andre available July 18th.
http://www.facebook.com/andrethaman
http://www.instagram.com/itsme_andre
http://www.twitter.com/itsme_andre985
http://www.soundcloud.com/andre985
Directed + Shot by @dunndealdesign
www.dunndealdesign.net
Adlens, the global leader in adjustable focus eyewear, has launched its ground-breaking adjustable prescription eyewear ‘AdlensFocuss™’, the greatest advancement in optics in more than 50 years.
Vision inevitably changes with age and people often need different strength glasses to see at near, intermediate and far distances. Progressive lenses are an option but they have a restricted usable lens area. A GFK Roper Study has shown one-third of wearers say they have trouble adjusting to them with seven to eight percent of wearers saying they cannot adjust to them at all.
AdlensFocuss provides the benefits of a single vision lens – full frame viewing area – with the best features of a progressive lens – the ability to see at different distances. They are prescription glasses with proprietary technology; a unique flexible membrane that allows the power to be adjusted by simply turning small dials on the inside of the frames. AdlensFocuss lenses offer at least four times more viewing area than traditional progressive lenses and come encased in a fashion-forward frame from award-winning designer Blake Kuwahara.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544851-adlensfocuss-optics-technology/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Click: http://www.cdbaby.com/cd/ingramstreet3 Ingram Street's second single from their upcoming album entitled "Escapism"! With a smooth Neo-Soul vibe with pop appeal for you to groove to! Produced by Irving "Baby Boy" Johnson. Written by Ingram Street. Directed by Stephon Brown "Lavish Film Factory." Download available on ITUNES, Amazon Music, and CD Baby.
Calling All Astronauts release their sixth single of the Covid 19 pandemic. "Resist" (Single Version) on February 19th. Mixed by double Grammy winner Alan Branch (Nine Inch Nails, U2, Depeche Mode), Trump may have gone but the war on fascism is far from over, Resist charts the resurgence of ANTIFA as a broad spectrum of people say "enough is enough" and stand together against the rise of populism and far right politics determined that another Kristallnacht (Night of broken glass) can't be allowed to happen.
In true DIY ethics not only did the guys recorded the track themselves, they have also once again made the accompanying video, this time remaking War Of The Worlds in just 3 minutes please check it out
Spotify - Deezer - Apple Music
The new SnowShredder™ serrated auger on single-stage snowblowers built by the Briggs & Stratton Power Products Group lets you easily clear snow and ice, including that tough and compacted end-of-the-driveway snow left behind by the snowplow. When matched with the Briggs & Stratton 1150 Snow Series™ engine, you can clear snow more than 30% faster compared to the Company’s other single stage snowthrowers.1
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7317651-snowshredder-serrated-auger-simplicity-snapper-briggs-and-stratton-snowblowers/
